HLB Genex (187420) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, HLB Genex (187420) reported revenue of 43.4 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202543.4 billion KRW1.2 billion KRW22.9 billion KRW[source]
202435.4 billion KRW-1.9 billion KRW-17.9 billion KRW[source]
202327.0 billion KRW-9.5 billion KRW-722 million KRW[source]
202227.8 billion KRW-6.2 billion KRW-13.4 billion KRW[source]
202125.9 billion KRW-3.8 billion KRW-8.5 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025105.1 billion KRW57.1 billion KRW48.0 billion KRW[source]
2024115.0 billion KRW91.9 billion KRW23.1 billion KRW[source]
202360.9 billion KRW35.1 billion KRW25.9 billion KRW[source]
202290.1 billion KRW53.5 billion KRW36.6 billion KRW[source]
202195.9 billion KRW34.0 billion KRW61.9 billion KRW[source]

Cash Flow

YearOperatingInvestingFinancingSource
20253.5 billion KRW-34.6 billion KRW-19.4 billion KRW[source]
20242.9 billion KRW6.5 billion KRW51.4 billion KRW[source]
2023-4.8 billion KRW38.0 billion KRW-21.3 billion KRW[source]
2022-4.7 billion KRW-13.1 billion KRW22.9 billion KRW[source]
2021-2.4 billion KRW-6.9 billion KRW-36 million KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice